Alpha Cognition prospectus offering, warrant listing
2021-10-01 17:57 ET - Prospectus Approved
Short form base shelf prospectus
Effective Oct. 1, 2021, the company's amended and restated short form base shelf prospectus dated Sept. 28, 2021, was filed with and accepted by the TSX Venture Exchange, and filed with and receipted by the British Columbia Securities Commission, pursuant to the provisions of the Securities Act in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario New Brunswick, Nova Scotia, Prince Edward Island, and Newfoundland and Labrador.
The TSX Venture Exchange has been advised that closing occurred on Oct. 1, 2021, for gross proceeds of $14,403,750.
Agents: Raymond James Ltd. and iA Private Wealth Inc.
Offering: 9,602,500 units (Each unit consists of one share and one warrant.)
Unit price: $1.50 per unit
Warrant exercise price/term: $1.75 per share for a 24-month period
Agents' warrants: 659,627 agent's warrants that are exercisable into common shares at $1.50 per share for a 24-month period
Supplemental listing of warrants
Effective at the opening, Oct. 5, 2021, the 9,602,500 warrants of the company will commence trading on the TSX Venture Exchange. The company is classified as a pharmaceutical and medicine manufacturing company.
Corporate jurisdiction: British Columbia
Capitalization: 9,602,500 warrants, authorized by a warrant indenture dated Oct. 1, 2021, of which 9,602,500 warrants are issued and outstanding
Transfer agent: Computershare Trust Company of Canada
Trading symbol: ACOG.WT
Cusip No.: 02074J 13 9
The warrants were issued pursuant to the short form base shelf prospectus offering of 9,602,500 units, which closed on Oct. 1, 2021. Each warrant entitles the holder to purchase one share at a price of $1.75 per share and will expire on Oct. 1, 2023.
© 2021 Canjex Publishing Ltd. All rights reserved. |
